Ethanol is one of 183 small molecule programs targeting Arrhythmia. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
1931 competitors in COVID-19
Ethanol
COVID-19 Vaccine
Aldactone
Nexavar
Aquasol E
Benadryl
Statin
Selenium
Vit D
Interferon-Gamma
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources